Results 51 to 60 of about 49,377 (194)

Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques.

open access: yesPLoS ONE, 2013
BackgroundPneumococcal pneumonia causes significant morbidity and mortality among adults. Given limitations of diagnostic tests for non-bacteremic pneumococcal pneumonia, most studies report the incidence of bacteremic or invasive pneumococcal disease ...
Maria A Said   +47 more
doaj   +1 more source

Pneumococcal vaccination and chronic respiratory diseases

open access: yesInternational Journal of Chronic Obstructive Pulmonary Disease, 2017
Patients with COPD and other chronic respiratory diseases are especially vulnerable to viral and bacterial pulmonary infections, which are major causes of exacerbations, hospitalization, disease progression, and mortality in COPD patients. Effective vaccines could reduce the burden of respiratory infections and acute exacerbations in COPD patients, but
F. Froes, N. Roche, F. Blasi
openaire   +7 more sources

Rare but not forgotten: A case of meningitis due to ceftriaxone-resistant Streptococcus pneumoniae

open access: yesIDCases, 2018
Despite the dramatic decrease in invasive pneumococcal disease since the widespread use of the first pneumococcal vaccine, invasive and resistant disease still occurs.
Naomi Hauser   +3 more
doaj   +1 more source

Easy Diagnosis of Invasive Pneumococcal Disease

open access: yesEmerging Infectious Diseases, 2011
Invasive pneumococcal disease (IPD) causes many cases of severe disease and death among children
Selva Jové, Laura   +3 more
openaire   +4 more sources

Use and efficacy of pneumococcal vaccine in patients with Hodgkin disease [PDF]

open access: bronze, 1979
AM Levine   +5 more
openalex   +1 more source

Pneumococcal whole-cell and protein-based vaccines: changing the paradigm

open access: yesExpert Review of Vaccines, 2017
Introduction: Epidemiologic evaluations of Streptococcus pneumoniae nasopharyngeal (NP) colonization and pneumococcal disease suggest that newer serotypes in future formulations of pneumococcal conjugate vaccines (PCVs) are needed and there may need to ...
Michael E. Pichichero
doaj   +1 more source

Population-based estimates of the effectiveness of pneumococcal vaccination in Australia

open access: yesInternational Journal of Population Data Science, 2017
Objectives Australia’s Childhood Immunisation Register (ACIR) is one of only a handful of national immunisation registers world-wide. We have, for the first time, linked the ACIR to other health datasets to measure the real-world impact of Australia’s ...
Heather Gidding   +6 more
doaj   +1 more source

Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review.

open access: yesPLoS ONE, 2019
BackgroundDespite the widespread implementation of the pneumococcal conjugate vaccine, Streptococcus pneumoniae remains the leading cause of severe pneumonia associated with mortality among children less than 5 years of age worldwide, with the highest ...
James Samwel Ngocho   +6 more
doaj   +1 more source

Evolution of antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolated from children with invasive and noninvasive pneumococcal diseases in Algeria from 2005 to 2012

open access: yesNew Microbes and New Infections, 2015
Pneumococcal infections are a major cause of morbidity and mortality in developing countries. The introduction of pneumococcal conjugate vaccines (PCVs) has dramatically reduced the incidence of pneumococcal diseases. PCVs are not currently being used in
N. Ramdani-Bouguessa   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy